Suchergebnisse - "Jones, John R"

PubPharm (145)

11

Estimating phytoplankton stoichiometry from routinely collected monitoring data

enthalten in: Biogeochemistry | 2022

von Yuan, L. | Jones, J.

12

Estimating phytoplankton stoichiometry from routinely collected monitoring data

enthalten in: Biogeochemistry | 2022

von Yuan, L. | Jones, J.

13

Nonlinear multidecadal trends in organic matter dynamics in Midwest reservoirs are a function of variable hydroclimate

enthalten in: Limnology and Oceanography | 2022

von Bhattacharya, R. | Jones, J. | Graham, J. | +4

14

Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation

enthalten in: Expert opinion on drug safety | 2021

von Jones, J. | Pawlyn, C. | Jackson, G.

15

Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial

enthalten in: Haematologica | 2021

von Jackson, G. | Davies, F. | Pawlyn, C. | +21

16

Widespread deoxygenation of temperate lakes

enthalten in: Nature | 2021

von Jane, S. | Hansen, G. | Kraemer, B. | +41

17

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma : results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial

enthalten in: British journal of haematology | 2021

von Jackson, G. | Pawlyn, C. | Cairns, D. | +21

18

Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+) : Interim analysis of an open-label randomised controlled trial

enthalten in: PLoS medicine | 2021

von Jackson, G. | Pawlyn, C. | Cairns, D. | +21

19

Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation

enthalten in: Expert opinion on drug safety | 2021

von Jones, J. | Pawlyn, C. | Jackson, G.

20

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma : results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial

enthalten in: British Journal of Haematology | 2021

von Jackson, G. | Pawlyn, C. | Cairns, D. | +20